Fosamprenavir Versus Other Protease Inhibitors

NCT00094523 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

314

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus I

Interventions

DRUG: Fosamprenavir

Sponsor

ViiV Healthcare

Collaborators

[object Object]